Alembic Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target
Alembic Pharmaceuticals Limited Financial Estimates
Alembic Pharmaceuticals Limited Revenue Estimates
Alembic Pharmaceuticals Limited EBITDA Estimates
Alembic Pharmaceuticals Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | 3/31/2027 | ||
Revenue
% change YoY
| ₹52.76B N/A | ₹52.31B -0.84% | ₹62.28B 19.05% | Avg: ₹77.44B Low: ₹74.73B High: ₹80.03B avg. 24.34% | Avg: ₹86.26B Low: ₹83.56B High: ₹88.47B avg. 11.38% | ||
Net Income
% change YoY
| ₹11.46B N/A | ₹5.20B -54.56% | ₹6.15B 18.21% | Avg: ₹8.57B Low: ₹7.90B High: ₹10.67B avg. 39.30% | Avg: ₹11.16B Low: ₹8.76B High: ₹11.90B avg. 30.09% | ||
EBITDA
% change YoY
| ₹15.67B N/A | ₹9.25B -40.95% | ₹9.61B 3.90% | Avg: ₹15.72B Low: ₹15.17B High: ₹16.25B avg. 63.53% | Avg: ₹17.51B Low: ₹16.96B High: ₹17.96B avg. 11.38% | ||
EPS
% change YoY
| $59.18 N/A | $26.5 -55.22% | $31.33 18.22% | Avg: $44.09 Low: $40.2 High: $54.3 avg. 40.74% | Avg: $55.11 Low: $44.6 High: $60.55 avg. 24.97% | ||
Operating Expenses
% change YoY
| ₹24.58B N/A | ₹29.16B 18.62% | ₹15.86B -45.57% | Avg: ₹16.86B Low: ₹16.27B High: ₹17.42B avg. 6.24% | Avg: ₹18.77B Low: ₹18.19B High: ₹19.26B avg. 11.38% | ||
FAQ
What is Alembic Pharmaceuticals Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 34.69% in 2026-2027.
We have gathered data from 11 analysts. Their low estimate is 7.90B, average is 8.57B and high is 10.67B.
What is Alembic Pharmaceuticals Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 17.86% in 2026-2027.
We have gathered data from 11 analysts. Their low revenue estimate is ₹74.73B, average is ₹77.44B and high is ₹80.03B.
What is Alembic Pharmaceuticals Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 32.86% in 2026-2027.
We have gathered data from 11 analysts. Their low earnings per share estimate is $40.2, average is $44.09 and high is ₹54.3.